Cerebral Vasospasm: A Review.
Findlay JM, Nisar J, Darsaut T.
Can J Neurol Sci. 2016 Jan;43(1):15-32. doi: 10.1017/cjn.2015.288. Epub 2015 Sep 2.
Reversible cerebral vasoconstriction syndrome.
Ducros A.
Lancet Neurol. 2012 Oct;11(10):906-17. doi: 10.1016/S1474-4422(12)70135-7.
Aneurysmal Subarachnoid Hemorrhage: Review of the Pathophysiology and Management Strategies.
Osgood ML.
Curr Neurol Neurosci Rep. 2021 Jul 26;21(9):50. doi: 10.1007/s11910-021-01136-9.
Reversible cerebral vasoconstriction syndrome: A review of pathogenesis, clinical presentation, and treatment.
Singhal AB.
Int J Stroke. 2023 Dec;18(10):1151-1160. doi: 10.1177/17474930231181250. Epub 2023 Jun 12.
"Triple-H" therapy for cerebral vasospasm following subarachnoid hemorrhage.
Lee KH, Lukovits T, Friedman JA.
Neurocrit Care. 2006;4(1):68-76. doi: 10.1385/NCC:4:1:068.
A Review of the Management of Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage.
Li K, Barras CD, Chandra RV, Kok HK, Maingard JT, Carter NS, Russell JH, Lai L, Brooks M, Asadi H.
World Neurosurg. 2019 Jun;126:513-527. doi: 10.1016/j.wneu.2019.03.083. Epub 2019 Mar 18.
Cerebral vasospasm.
Baggott CD, Aagaard-Kienitz B.
Neurosurg Clin N Am. 2014 Jul;25(3):497-528. doi: 10.1016/j.nec.2014.04.008.
Clazosentan: First Approval.
Lee A.
Drugs. 2022 Apr;82(6):697-702. doi: 10.1007/s40265-022-01708-0.
Cerebral arterial spasm. A short review.
POTTER JM.
World Neurol. 1961 Jul;2:576-88.
Cerebral vasospasm.
Agner C.
Neurol Res. 2009 Jul;31(6):553-6. doi: 10.1179/174313209X455763.
